2breathe Technologies Ltd.

2breathe Technologies Ltd. and its founders are pioneers in the development of the digital therapeutic devices field, first in hypertension and now in sleeplessness. The original product, RESPeRATE® (www.resperate.com), is the world’s first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients is featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE guided-breathing technology for individuals who have difficulties falling asleep. 2breathe is not a medical device and is not intended to diagnose or treat medical conditions.